Search Results - "Price II, W Nicholson"

REGULATING BLACK-BOX MEDICINE by Price, W. Nicholson

“…Data drive modern medicine. And our tools to analyze those data are growing ever more powerful. As health data are collected in greater and greater amounts,…”
Get full text

Digital Simulacra, Bias, and Self-Reinforcing Exclusion Cycles by Bracic, Ana, Price II, W. Nicholson

Get full text

Hierarchy, race, and gender in legal scholarly networks by Nunna, Keerthana, Price, W. Nicholson, II, Tietz, Jonathan

“…A potent myth of legal academic scholarship is that it is mostly meritocratic and mostly solitary. Reality is more complicated. In this article we plumb the…”
Get full text

Understanding the physical properties that control protein crystallization by analysis of large-scale experimental data by Hunt, John F, Price II, W Nicholson, Chen, Yang, Handelman, Samuel K, Neely, Helen, Manor, Philip, Karlin, Richard, Nair, Rajesh, Liu, Jinfeng, Baran, Michael, Everett, John, Tong, Saichiu N, Forouhar, Farhad, Swaminathan, Swarup S, Acton, Thomas, Xiao, Rong, Luft, Joseph R, Lauricella, Angela, DeTitta, George T, Rost, Burkhard, Montelione, Gaetano T

“…The physical properties that determine the propensity of a protein to form a well-ordered crystal suitable for structure determination are poorly understood…”
Get full text

Diagnosing bias in data-driven algorithms for healthcare by Wiens, Jenna, Price, W. Nicholson, Sjoding, Michael W.

“…A recent analysis highlighting the potential for algorithms to perpetuate existing racial biases in healthcare underscores the importance of thinking carefully…”
Get full text

An administrative fix for manufacturing process patent thickets by Rai, Arti K., Price, W. Nicholson

“…Biosimilar manufacturing process patent applications first filed more than a year after the biologic is approved, which represent the largest source of patent…”
Get full text

Negative innovation: when patents are bad for patients by Feldman, Robin C., Hyman, David A., Price, W. Nicholson, Ratain, Mark J.

“…Incentives in patent law have driven innovation into spaces that are affirmatively harmful to patients, and patentees are discouraged from taking steps to…”
Get full text

CRYPTIC PATENT REFORM THROUGH THE INFLATION REDUCTION ACT by Rai, Arti K, Sachs, Rachel E, Price, W. Nicholson, II

“…If a statute substantially changes the way patents work in an industry where patents are central, but says almost nothing about patents, is it patent reform?…”
Get full text

Clearing Opacity Through Machine Learning by Price, W. Nicholson, II, Rai, Arti K

“…Artificial intelligence and machine learning represent powerful tools in many fields, ranging from criminal justice to human biology to climate change. Part of…”
Get full text

Manufacturing barriers to biologics competition and innovation by Price, W. Nicholson, II, Rai, Arti K

“…As finding breakthrough small-molecule drugs becomes more difficult, drug companies are increasingly turning to "large molecule" biologics. Although biologics…”
Get full text

Expired patents, trade secrets, and stymied competition by Price, W. Nicholson, II

“…Patents and trade secrecy have long been considered substitute incentives for innovation. When inventors create a new invention, they traditionally must choose…”
Get full text

Regulating secrecy by Price, W. Nicholson, II

“…Inventors face a stark choice between two intellectual property systems of protecting innovative ideas: patents and trade secrecy. But accounts of this choice…”
Get full text

Covid-19, single-sourced diagnostic tests, and innovation policy by Deb, Chaarushena, Moneer, Osman, Price, W Nicholson

Get full text

Humans in the Loop by Crootof, Rebecca, Kaminski, Margot E, Price, W. Nicholson

“…From lethal drones to cancer diagnostics, humans are increasingly working with complex and artificially intelligent algorithms to make decisions which affect…”
Get full text

Mapping the patent landscape of medical machine learning by Aboy, Mateo, Price, W. Nicholson, Raker, Seth

“…Patent office data show robust and rising patenting of AI inventions in the medical field, contrary to fears that medical machine learning patents might be…”
Get full text

The sufficiency of disclosure of medical artificial intelligence patents by Aboy, Mateo, Price, W. Nicholson, Raker, Seth, Liddell, Kathleen

“…Analysis of medical artificial intelligence patents reveals substantial gaps in disclosure, underscoring the need for improved examination guidelines to ensure…”
Get full text

Translating Commercial Health Data Privacy Ethics into Change by Spector-Bagdady, Kayte, Price, W. Nicholson

Get full text

Enabling collaborative governance of medical AI by Price, W. Nicholson, Sendak, Mark, Balu, Suresh, Singh, Karandeep

“…Medical artificial intelligence needs governance to ensure safety and effectiveness, not just centrally (for example, by the US Food and Drug Administration)…”
Get full text

Use of Artificial Intelligence in Drug Development by Druedahl, Louise C, Price, 2nd, W Nicholson, Minssen, Timo, Sarpatwari, Ameet

“…This cross-sectional study investigates the scope and breadth of artificial intelligence use in drug development…”
Get full text

Will clinical trial data disclosure reduce incentives to develop new uses of drugs? by Price, W Nicholson, Minssen, Timo

Get full text